Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 12,699.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,699.4% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,059.12% |
TMC the metals (TMC) | 550% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 511.41% |
Centrus Energy (LEU) | 408.72% |
Opendoor Technologies (OPEN) | 399.08% |
Mercurity Fintech Holding Inc ADR (MFH) | 340.93% |
Ondas (ONDS) | 296.4% |
Celcuity LLC (CELC) | 282.07% |
Cidara Therapeutics (CDTX) | 276.21% |
Planet Labs PBC (PL) | 274.33% |
Ramaco Resources (METC) | 271.45% |
GRAIL, LLC (GRAL) | 267.82% |
Sandisk (SNDK) | 266.26% |
ViaSat (VSAT) | 264.32% |
American Bitcoin (ABTC) | 250.75% |
Applied Digital (APLD) | 237.96% |
SSR Mining (SSRM) | 231.68% |
DRDGOLD Limited ADR (DRD) | 231.3% |
Sibanye Gold Ltd ADR (SBSW) | 227.57% |
Energy Fuels (UUUU) | 214.67% |
Pagaya Technologies (PGY) | 209.15% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 208.68% |
Uniqure (QURE) | 207.68% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
